COVID-19, the syndrome caused by the novel coronavirus SARS-CoV-2, has spread throughout the world, causing the death of at least three million people. For the over 81 million who have recovered, however, the long-term effects are only beginning to manifest. We performed a bilateral lung transplant on a 31-year-old male patient for chronic hypoxic respiratory failure, severe pulmonary hypertension and radiographically identified pulmonary fibrosis five months after an acute COVID-19 infection. The explant demonstrated moderate pulmonary vascular remodeling with intimal thickening and medial hypertrophy throughout, consistent with pulmonary hypertension. The parenchyma demonstrated an organizing lung injury in the proliferative phase, with severe fibrosis, histiocytic proliferation, type II pneumocyte hyperplasia, and alveolar loss consistent with known COVID-19 pneumonia complications.

This report highlights a novel histologic finding in severe, chronic COVID-19. Although the findings in acute COVID-19 pneumonia have been well-examined at autopsy, the chronic course of this complex disease is not yet understood. The case presented herein suggests that COVID-induced pulmonary hypertension may become more common as more patients survive severe SARS-CoV-2-related pneumonia. Pulmonologists and pulmonary pathologists should be aware of this possible association and look for the clinical, radiographic, and histologic criteria in the appropriate clinical setting.

1. Moline, H, Whitaker, M, Deng, L, et al. Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years — COVID-NET, 13 States, February–April 2021. Vol. 70. 2021:1088-1093. Morbidity and Mortality Weekly Report. August 13, 2021.
Google Scholar2. Greenhalgh, T, Knight, M, A'Court, C, Buxton, M, Husain, L. Management of post-acute covid-19 in primary care. BMJ. Aug. 11 2020;370(m3026). doi:10.1136/bmj.m3026
Google Scholar | Crossref3. Alshomrani, A, Rohr, J, Carda, M, et al. A Sticky Issue: Thrombotic Phenomena Amidst Autopsy Findings in Fatal Cases of COVID-19. Video and abstract, United States and Canadian Academy of Pathology Annual Meeting (virtual meeting), March 2021.
Google Scholar4. Elsoukkary, SS, Mostyka, M, Dillard, A, et al. Autopsy findings in 32 patients with COVID-19: a single-institution experience. Pathobiology. 2021;88(1):56-68. doi:10.1159/000511325
Google Scholar | Crossref | Medline5. Satturwar, S, Fowkes, M, Farver, C, et al. Postmortem findings associated With SARS-CoV-2: systematic review and meta-analysis. Am J Surg Pathol. May 1 2021;45(5):587-603. doi:10.1097/PAS.0000000000001650
Google Scholar | Crossref | Medline6. Dong, E, Du, H, Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. May 2020;20(5):533-534. doi:10.1016/S1473-3099(20)30120-1
Google Scholar | Crossref | Medline7. Sudre, CH, Murray, B, Varsavsky, T, et al. Attributes and predictors of long COVID. Nat Med. Apr 2021;27(4):626-631. doi:10.1038/s41591-021-01292-y
Google Scholar | Crossref | Medline8. Aesif, SW, Bribriesco, AC, Yadav, R, et al. Pulmonary pathology of COVID-19 following 8 weeks to 4 months of severe disease: a report of three cases, including One With bilateral lung transplantation. Am J Clin Pathol. Mar 15 2021;155(4):506-514. doi:10.1093/ajcp/aqaa264
Google Scholar | Crossref | Medline9. Bharat, A, Querrey, M, Markov, NS, et al. Lung transplantation for patients with severe COVID-19. Sci Transl Med. Dec 16 2020;12(574). doi:10.1126/scitranslmed.abe4282
Google Scholar | Crossref | Medline10. Bharat, A, Machuca, TN, Querrey, M, et al. Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries. Lancet Respir Med. Mar 31 2021;9(5):487–497. doi:10.1016/S2213-2600(21)00077-1
Google Scholar | Crossref11. Lee, JD, Burger, CD, Delossantos, GB, et al. A survey-based estimate of COVID-19 incidence and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension and impact on the process of care. Ann Am Thorac Soc. Dec 2020;17(12):1576-1582. doi:10.1513/AnnalsATS.202005-521OC
Google Scholar | Crossref | Medline12. Suzuki, YJ, Nikolaienko, SI, Shults, NV, Gychka, SG. COVID-19 patients may become predisposed to pulmonary arterial hypertension. Med Hypotheses. Feb 2021;147:110483. doi:10.1016/j.mehy.2021.110483
Google Scholar | Crossref | Medline13. Plebani, M . Persistent viral RNA shedding in COVID-19: caution, not fear. EBioMedicine. Feb 2021;64:103234. doi:10.1016/j.ebiom.2021.103234
Google Scholar | Crossref | Medline